⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CLDI News
Calidi Biotherapeutics, Inc.
Calidi Biotherapeutics To Present on its New Approach to Bispecific T-Cell Engagers (BiTEs) Using its RedTail Platform in a Late-Breaking Abstract at the 2026 AACR-IO Conference
globenewswire.com
CLDI
Calidi Biotherapeutics Provides Corporate Update and Key Value Drivers for 2026
globenewswire.com
CLDI
Calidi Biotherapeutics and Nova Minerals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
accessnewswire.com
CLDI
NVA
Calidi Biotherapeutics Announces Exclusive Live Investor Webinar and Q&A Session on November 19, 2025
globenewswire.com
CLDI
Calidi Biotherapeutics Reports Third Quarter 2025 Financial Results and Recent Operational Highlights
globenewswire.com
CLDI
Calidi Biotherapeutics Presents New Data on its Therapeutic Lead, CLD-401, at the 2025 SITC Annual Meeting and Holds Its First Investor Day at SITC
globenewswire.com
CLDI
Calidi Biotherapeutics Announces Investor Event to be Held on Friday, November 7th at the 2025 SITC Annual Meeting
globenewswire.com
CLDI
Matica Bio, a CDMO Leader in Oncolytic Virus Manufacturing, Partners with Calidi Biotherapeutics to Advance Calidi's Project Toward IND
prnewswire.com
CLDI
Calidi Biotherapeutics Announces New Data to be Presented on its Therapeutic Lead, CLD-401, at the 2025 SITC Annual Meeting
globenewswire.com
CLDI
Calidi Biotherapeutics to Present at the second annual Oncology Venture, Innovation, and Partnering Summit in Boston
globenewswire.com
CLDI